Measurement of myocardial infarct size from plasma fatty acid-binding protein or myoglobin, using individually estimated clearance rates

Cardiovascular Research

Volumn 44, Issue 2, 1999, Pages 315-324

  De Groot, Monique J M ^a   Wodzig, K Will H ^b   Simoons, Maarten L ^c   Glatz, Jan F C ^a   Hermens, Wim Th ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Enzyme (kinetics); Infarction; Renal function

Indexed keywords

2 HYDROXYBUTYRATE DEHYDROGENASE; BIOCHEMICAL MARKER; CREATINE KINASE; CREATINE KINASE MB; FATTY ACID BINDING PROTEIN; HEPARIN; MYOGLOBIN; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ACCURACY; ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CREATININE BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART INFARCTION SIZE; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PLASMA CLEARANCE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TECHNIQUE;

ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CARRIER PROTEINS; CREATINE KINASE; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; HYDROXYBUTYRATE DEHYDROGENASE; KIDNEY; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; MYELIN P2 PROTEIN; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOGLOBIN; NEOPLASM PROTEINS; STATISTICS, NONPARAMETRIC; TIME FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 0033231994     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00199-6     Document Type: Article

References (32)

1. Ellis A.K., Little Th., Masud A.R.Z., et al. Early noninvasive detection of successful reperfusion in patients with acute myocardial infarction. Circulation. 78:1988;1352-1357.
2. Mair J., Artner-Dworzak E., Lechleiter P., et al. Early diagnosis of acute myocardial infarction by a newly developed rapid immunoturbidimetric assay for myoglobin. Br Heart J. 68:1992;462-468.
3. Van Nieuwenhoven F.A., Kleine A.H., Wodzig K.W.H., et al. Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. Circulation. 92:1995;2848-2854.
4. Ishii J., Wang J.-H., Naruse H., et al. Serum concentrations of myoglobin vs. heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction. Clin Chem. 43:1997;1372-1378.
5. Hall C.L., Hardwicke J. Low molecular weight proteinuria. Ann Rev Med. 30:1979;199-211.
6. Rabkin R., Dahl D.C. Renal uptake and disposal of proteins and peptides. Audus K.I., Raub T.J., Biological barriers to protein delivery. 1993;299-338 Plenum Press, New York.
7. Gorski J., Hermens W.Th., Borawski J., Mysliwiec M., Glatz J.F.C. Increased fatty acid-binding protein concentration in plasma of patients with chronic renal failure. Clin Chem. 43:1997;193-195.
8. Wodzig K.W.H., Kragten J.A., Hermens W.Th., Glatz J.F.C., Van Dieijen-Visser M.P. Estimation of myocardial infarct size from plasma myoglobin or fatty acid-binding protein. Influence of renal function. Eur J Clin Chem Clin Biochem. 35:1997;191-198.
9. Glatz J.F.C., Kleine A.H., Van Nieuwenhoven F.A., et al. Fatty-acid-binding protein as a plasma marker for the estimation of myocardial infarct size in humans. Br Heart J. 71:1994;135-140.
10. Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron. 16:1976;31-41.
11. Gault M.H., Longerich L.L., Harnett J.D., Wesolowski C. Predicting glomerular function from adjusted serum creatinine. Nephron. 62:1992;249-256.
12. Baardman T., Hermens W.Th., Lenderick T., et al. Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency, The GUSTO Enzyme Substudy. Eur Heart J. 17:1996;237-246.
13. The GUSTO Angiographic Investigators . The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med. 329:1993;1615-1622.
14. Wodzig K.W.H., Pelsers M.M.A.L., Van der Vusse G.J., Roos W., Glatz J.F.C. One-step enzyme-linked immunosorbent assay (ELISA) for plasma fatty acid-binding protein. Ann Clin Biochem. 34:1997;263-268.
15. Willems G.M., Visser M.P., Krill M.T.A., Hermens W.Th. Quantitative analysis of plasma enzyme levels based upon simultaneous determination of different enzymes. Cardiovasc Res. 16:1982;120-131.
16. Groth T., Sylvén C. Myoglobin kinetics in patients suffering from acute myocardial infarction in its early phase - as studied by the single injection method. Scand J Clin Lab Invest. 41:1981;79-85.
17. Geigy, Wissenschaftliche Tabellen, Korperflussigkeiten 8, Basel, 1977.
18. Van der Laarse A., Dijkshoorn N.J., Hollaar L., Caspers T. The (iso-)enzyme activities of lactate dehydrogenase, alphahydroxybutyrate dehydrogenase, creatine kinase and aspartate aminotransferase in human myocardial biopsies and autopsies. Clin Chim Acta. 104:1980;381-391.
19. Kragten J.A., Van Nieuwenhoven F.A., Van Dieijen-Visser M.P. Distribution of myoglobin and fatty-acid binding protein in human cardiac autopsies. Clin Chem. 42:1996;337-338.
20. Siegel S., Castellan N.J. Nonparametric statistics for the behavioral sciences. 1988;McGraw-Hill, New York.
21. Willems G.M., van der Veen F.H., Huysmans H.A., et al. Enzymatic assessment of myocardial necrosis after cardiac surgery: differentiation from skeletal muscle damage, hemolysis and liver injury. Am Heart J. 109:1985;1243-1252.
22. Smit M.J., Duursma A.M., Bouma J.M.W. Receptor-mediated endocytosis of lactate dehydrogenase M4 by liver macrophages: a mechanism for elimination of enzymes from plasma. J Biol Chem. 262:1987;13020-13026.
23. Hermens W.Th., Willems G.M., Visser M.P. Quantification of circulating proteins. 1982;Martinus Nijhoff, Boston. Ch. 2.
24. Myers B.D., Guasch A. Selectivity of the glomerular filtration barrier in healthy and nephrotic humans. Am J Nephrol. 13:1993;311-317.
25. Renkin E.M., Curry F.E. Transport of water and solutes across capillary endothelium. Giebisch G., Tosteson D.C., Ussing H.H., Membrane transport in biology. 1979;1-45 Springer Verlag, Berlin.
26. Bohrer M.P., Baylis C., Humes H.D., et al. Permselectivity of the glomerular capillary wall: Facilitated filtration of circulating polycations. J Clin Invest. 61:1978;72-78.
27. Wodzig K.W.H., Kragten J.A., Modrzejewski W., et al. Thrombolytic therapy does not change the release ratios of enzymatic and non-enzymatic myocardial marker proteins. Clin Chim Acta. 272:1998;209-223.
28. Van der Veen F.H., Visser R., Willems G.M., Kop-Klaassen B., Hermens W.Th. Myocardial enzyme depletion in infarcted human hearts: infarct size and equivalent tissue mass. Cardiovasc Res. 22:1988;611-619.
29. Van der Laarse A., Hollaar L., Vliegen H.W., et al. Myocardial (iso)enzyme activities, DNA concentration and nuclear polyploidy in hearts of patients operated upon for congenital heart disease, and in normal and hypertrophic adult human hearts at autopsy. Eur J Clin Invest. 19:1989;192-200.
30. Nascimben L., Ingwall J.S., Pauletto P., et al. Creatine kinase system in failing and nonfailing human myocardium. Circulation. 94:1996;1894-1901.
31. Ohman E.M., Armstrong P.W., Christenson R.H., et al. For the GUSTO-IIa Investigators. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med. 335:1996;1333-1341.
32. Antman E.M., Tanasijevic M.J., Thompson B., et al. Cardiac-specific troponin I levels predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 335:1996;1342-1349.